STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the U.S. Food and ...
Please provide your email address to receive an email when new articles are posted on . Intraocular lens surgery was once seen as a last resort for patients interested in spectacle independence, but ...
FALLS CHURCH, VA - February 04, 2026 - PRESSADVANTAGE - A new article, "Who offers financing or payments for vision ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL
Oct. 10, 2023 10:51 AM ETSTAAR Surgical Company (STAA) STAAR Surgical is equally enthusiastic about this collaboration. Tom Frinzi, CEO of STAAR Surgical, states, "We are happy to have Jimmy O. Yang ...
(RTTNews) - STAAR Surgical Company (STAA) Tuesday announced partnership with ophthalmology group, SharpeVision to provide EVO ICL lenses to all qualified patients in SharpeVision clinics. STAAR ...
MIAMI – The pandemic has brought a significant increase in vision complaints, partly fueled during the pandemic as people spent more time than ever staring at screens. The surge in nearsightedness, or ...
“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results